Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area

Addiction Biology

Volumn 18, Issue 6, 2013, Pages 930-936

  Simonnet, Amelie ^a   Cador, Martine ^a   Caille, Stephanie ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

AM 251; intravenous self administration; nicotine; nucleus accumbens; rat; ventral tegmental area

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; NICOTINE; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

AM 251; INTRAVENOUS SELF-ADMINISTRATION; NICOTINE; NUCLEUS ACCUMBENS; RAT; VENTRAL TEGMENTAL AREA;

ANIMALS; CANNABINOID RECEPTOR ANTAGONISTS; CATHETERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, INTRAVENTRICULAR; NICOTINE; NUCLEUS ACCUMBENS; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; VENTRAL TEGMENTAL AREA;

EID: 84889253008     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00476.x     Document Type: Article

References (41)

1. Besson M, David V, Baudonnat M, Cazala P, Guilloux JP, Reperant C, Cloez-Tayarani I, Changeux JP, Gardier AM, Granon S, (2011) Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice. Psychopharmacology (Berl) 220: 1-14.
2. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF, (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70: 515-530. (Pubitemid 34131646)
3. Caille S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH, (2007) Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 27: 3695-3702. (Pubitemid 46557675)
4. Caille S, Guillem K, Cador M, Manzoni O, Georges F, (2009) Voluntary nicotine consumption triggers in vivo potentiation of cortical excitatory drives to midbrain dopaminergic neurons. J Neurosci 29: 10410-10415.
5. Caille S, Parsons LH, (2006) Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway. Neuropsychopharmacology 31: 804-813.
6. Caillé S, Parsons LH, (2003) SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in the nucleus accumbens in rats. Eur J Neurosci 18: 3145-3149. (Pubitemid 38021557)
7. Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O, (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43: 857-867. (Pubitemid 35221396)
8. Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF, (2006) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) 184: 353-366. (Pubitemid 43255852)
9. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM, (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27: 791-795. (Pubitemid 46174497)
10. Clemens KJ, Caille S, Cador M, (2010) The effects of response operandum and prior food training on intravenous nicotine self-administration in rats. Psychopharmacology (Berl) 211: 43-54.
11. Cohen C, Perrault G, Griebel G, Soubrie P, (2005) Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology 30: 145-155. (Pubitemid 40024408)
12. Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P, (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13: 451-463. (Pubitemid 35178842)
13. Corrigall WA, Coen KM, Adamson KL, (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653: 278-284. (Pubitemid 24252850)
14. Corrigall WA, Franklin KB, Coen KM, Clarke PB, (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107: 285-289.
15. Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W, (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61-65. (Pubitemid 32037114)
16. David V, Besson M, Changeux JP, Granon S, Cazala P, (2006) Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50: 1030-1040. (Pubitemid 44208837)
17. Exley R, Clements MA, Hartung H, McIntosh JM, Cragg SJ, (2008) Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33: 2158-2166. (Pubitemid 351992087)
18. Exley R, Maubourguet N, David V, Eddine R, Evrard A, Pons S, Marti F, Threlfell S, Cazala P, McIntosh JM, Changeux JP, Maskos U, Cragg SJ, Faure P, (2011) Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine. Proc Natl Acad Sci USA 108: 7577-7582.
19. Forget B, Hamon M, Thiebot MH, (2005) Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 181: 722-734. (Pubitemid 41400758)
20. Gamaleddin I, Wertheim C, Zhu AZ, Coen KM, Vemuri K, Makryannis A, Goldberg SR, Le Foll B, (2012) Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addict Biol 17: 47-61.
21. Jones IW, Wonnacott S, (2004) Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 24: 11244-11252. (Pubitemid 39658259)
22. Kenny PJ, Chartoff E, Roberto M, Carlezon WA, Jr, Markou A, (2009) NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 34: 266-281.
23. Le Foll B, Goldberg SR, (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15: 2139-2143. (Pubitemid 39281762)
24. Luchicchi A, Lecca S, Carta S, Pillolla G, Muntoni AL, Yasar S, Goldberg SR, Pistis M, (2010) Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addict Biol 15: 277-288.
25. Lupica CR, Riegel AC, (2005) Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 48: 1105-1116. (Pubitemid 40725983)
26. Mansvelder HD, Keath JR, McGehee DS, (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33: 905-919. (Pubitemid 34246356)
27. Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, Goldberg SR, (2011) Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biol Psychiatry 69: 633-641.
28. McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK, (2011) Alpha4beta2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci 31: 10891-10902.
29. Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M, (2008) Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J Neurosci 28: 13985-13994.
30. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL, (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24: 53-62. (Pubitemid 38181669)
31. Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI, (2008) The endogenous cannabinoid system modulates nicotine reward and dependence. J Pharmacol Exp Ther 326: 483-492.
32. Nisell M, Nomikos GG, Svensson TH, (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16: 36-44. (Pubitemid 24013237)
33. Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF, Lichtman AH, Cheer JF, (2012) Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 73: 360-373.
34. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA, (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390: 401-404. (Pubitemid 28027320)
35. Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T, Dani JA, (2004) Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn Mem 11: 60-69. (Pubitemid 38167059)
36. Pontieri FE, Tanda G, Orzi F, Di Chiara G, (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-257. (Pubitemid 26251360)
37. Riegel AC, Lupica CR, (2004) Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 24: 11070-11078. (Pubitemid 40012966)
38. Shoaib M, (2008) The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology 54: 438-444.
39. Solinas M, Scherma M, Fattore L, Stroik J, Wertheim C, Tanda G, Fratta W, Goldberg SR, (2007) Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse. J Neurosci 27: 5615-5620. (Pubitemid 350021063)
40. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM, (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411. (Pubitemid 28062631)
41. Wing VC, Shoaib M, (2010) Second-order schedules of nicotine reinforcement in rats: effect of AM251. Addict Biol 15: 393-402.